Toxic effects of epidural analgesia with ropivacaine 0.2% in a diabetic patient

Journal of Clinical Anesthesia
Bassam Al-Nasser

Abstract

A 51-year-old ASA physical status II, non-insulin-dependent diabetic male patient manifested lower limb nerve injury after receiving postoperative epidural analgesia with ropivacaine 0.2%. The case is presented, including a discussion of the relation between local anesthetic toxicity and diabetic neuropathy.

References

Nov 1, 1985·Anaesthesia·H Flaatten, J Raeder
Oct 1, 1985·Anesthesiology·L B ReadyS M Sumi
May 1, 1993·Journal of Neuropathology and Experimental Neurology·M W KalichmanR R Myers
Jul 20, 2001·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·A I VinikG L Pittenger
Aug 29, 2001·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·G VittadiniG Biscaldi

❮ Previous
Next ❯

Citations

Oct 1, 2011·International Anesthesiology Clinics·Philipp LirkQuinn Hogan
Apr 17, 2012·Acta Anaesthesiologica Taiwanica : Official Journal of the Taiwan Society of Anesthesiologists·Bassam Al-Nasser
Apr 6, 2005·Journal of Clinical Anesthesia·Gregory W Seaman, Neil Roy Connelly
Jun 27, 2015·Regional Anesthesia and Pain Medicine·Sandra L KoppJames R Hebl
May 8, 2019·Artificial Cells, Nanomedicine, and Biotechnology·Yan ChenXianhui Yang
Dec 18, 2009·Anaesthesia and Intensive Care·Z ZhongS Zhihua
Mar 16, 2021·Der Anaesthesist·L BrandtU Artmeier-Brandt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.